Grifols GRFS
NASDAQ GRFS
$8.00 +0.01 (+0.13%)
At close: Aug 21, 2026 · 4:00 PM EDT

Grifols (GRFS) Other Operating Expenses (2010 - 2020)

Grifols' (GRFS) quarterly Other Operating Expenses came in at -$351.5 million in Q1 2020, down 4.15% YoY from -$366.8 million in Q2 2019, and up 64.6% on a QoQ basis from -$993.1 million in Q4 2019.

Grifols (GRFS) Other Operating Expenses (2010 - 2020) Analysis & Trends

Grifols (GRFS) has 11 years of Other Operating Expenses data on file, last reported at -$351.5 million in Q1 2020.

  • Quarterly Other Operating Expenses fell 4.15% year-over-year to -$351.5 million in Q1 2020, while the trailing twelve-month figure through Dec 2021 was -$351.5 million (up 73.85% YoY) and the FY2025 annual result came in at -$0.0, changed N/A from the prior year.
  • Other Operating Expenses advanced to -$351.5 million in Q1 2020, from -$993.1 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $1.2 billion in Q2 2018 to a low of -$993.1 million in Q4 2019.
  • A 5-year average of -$267.9 million and a median of -$308.1 million in 2017 frame the typical range for Other Operating Expenses.
  • Annual changes were most pronounced in 2017 — Other Operating Expenses slumped 4.1090625028680595e+17% — and 2018, when it soared 6860.64%.
  • Tracing GRFS's Other Operating Expenses over 5 years: stood at -$0.0 in 2016, then tumbled by 4.1090625028680595e+17% to -$979.7 million in 2017, then rose by 11.63% to -$865.8 million in 2018, then slipped by 14.7% to -$993.1 million in 2019, then soared by 64.6% to -$351.5 million in 2020.
  • The last three Other Operating Expenses figures came in at -$351.5 million (Q1 2020), -$993.1 million (Q4 2019), and -$337.5 million (Q1 2019), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Grifols 5.45 Bn 4.45 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2020 -351.55 Mn
Dec 31, 2019 -993.06 Mn
Mar 31, 2019 -337.55 Mn
Dec 31, 2018 -865.76 Mn
Jun 30, 2018 1.21 Bn
Mar 31, 2018 -300.11 Mn
Dec 31, 2017 -979.68 Mn
Jun 30, 2017 -17.86 Mn
Mar 31, 2017 -308.10 Mn
Dec 31, 2016 0.00
Sep 30, 2016 0.00
Jun 30, 2015 0.00
Mar 31, 2015 0.00
Dec 31, 2014 10.25 Mn
Dec 31, 2013 -333,466.94
Dec 31, 2012 8.72 Mn
Jun 30, 2012 1.01 Mn
Mar 31, 2012 135,065.50
Dec 31, 2011 -17.44 Mn
Sep 30, 2011 -32.57 Mn